Literature DB >> 22609818

Genetic polymorphisms of HO-1 and COX-1 are associated with aspirin resistance defined by light transmittance aggregation in Chinese Han patients.

Xiao-li Li1, Jian Cao, Li Fan, Qiang Wang, Ling Ye, Chun-Ping Cui, Ya-Zhen Wang, Lin Liu, Bin Li, Ruo-Jun Wu, Feng-chun Zhou, Jun-hong Zhang.   

Abstract

BACKGROUND: Cyclooxygenase 1 (COX-1), COX-2, and HO-1 are involved in the process of aspirin's effect. The genetic susceptibility of these enzymes to aspirin resistance (AR) is unclear.
METHODS: A total of 431 patients took aspirin. Using arachidonic acid-induced light transmittance aggregation combined with adenosine diphosphate-induced light transmittance aggregation, 36 participants served for AR, 164 participants for semi-AR, and 231 participants for aspirin sensitivity (AS). The AR with 9 single-nucleotide polymorphism in COX-1, COX-2, and HO-1 genes was investigated.
RESULTS: COX-1 rs1330344 (-1676A>G) is associated with AR. G-Allele carriers significantly increased the risk of AR. For patients with AS as control, P is .02 (odds ratio [OR] = 1.77, confidence interval [CI]: 1.07-2.92). For patients with semi-AR as control, P is .05. HO-1 rs2071746 (-413A>T) is associated with AR. T-Allele carriers significantly increased the risk of AR. For patients with AS as control, P is .04 (OR = 1.70, CI: 1.02-2.79). For patients with semi-AR as control, P is .05 (OR = 1.68, CI: 1.00-2.80).
CONCLUSION: rs2071746 in HO-1 gene, rs1330344 in COX-1 gene contribute to AR.

Entities:  

Keywords:  aspirin resistance; cyclooxygenase-1 (COX-1); hemoxygenase-1 (HO-1); platelet aggregation; single-nucleotide polymorphism (SNP)

Mesh:

Substances:

Year:  2012        PMID: 22609818     DOI: 10.1177/1076029612444002

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  7 in total

1.  Association of PON1, P2Y12 and COX1 with Recurrent Ischemic Events in Patients with Extracranial or Intracranial Stenting.

Authors:  Xiao-Qing Li; Ning Ma; Xin-Gang Li; Bo Wang; Shu-Sen Sun; Feng Gao; Da-Peng Mo; Li-Gang Song; Xuan Sun; Lian Liu; Xing-Quan Zhao; Yi-Long Wang; Yong-Jun Wang; Zhi-Gang Zhao; Zhong-Rong Miao
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

2.  The Effect of Xuefuzhuyu Oral Liquid on Aspirin Resistance and Its Association with rs5911, rs5787, and rs3842788 Gene Polymorphisms.

Authors:  Mei Xue; Lin Yang; Na Kou; Yu Miao; Mingming Wang; Quanli Zhao; Junhua Ren; Shaoyan Zhang; Dazhuo Shi; Keji Chen
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-01       Impact factor: 2.629

3.  Haem oxygenase protects against thrombocytopaenia and malaria-associated lung injury.

Authors:  Isaclaudia G de Azevedo-Quintanilha; Isabel M Medeiros-de-Moraes; André C Ferreira; Patrícia A Reis; Adriana Vieira-de-Abreu; Robert A Campbell; Andrew S Weyrich; Patricia T Bozza; Guy A Zimmerman; Hugo C Castro-Faria-Neto
Journal:  Malar J       Date:  2020-07-01       Impact factor: 2.979

4.  Effect of 106PEAR1 and 168PTGS1 genetic polymorphisms on recurrent ischemic stroke in Chinese patient.

Authors:  Jiali Zhao; Fudi Chen; Lin Lu; Hui Tang; Ruirui Yang; Yongxiang Wang; Yifeng Du
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

Review 5.  Aspirin Resistance in Vascular Disease: A Review Highlighting the Critical Need for Improved Point-of-Care Testing and Personalized Therapy.

Authors:  Hamzah Khan; Omar Kanny; Muzammil H Syed; Mohammad Qadura
Journal:  Int J Mol Sci       Date:  2022-09-26       Impact factor: 6.208

Review 6.  The association of four common polymorphisms from four candidate genes (COX-1, COX-2, ITGA2B, ITGA2) with aspirin insensitivity: a meta-analysis.

Authors:  Zhiyuan Weng; Xiaobo Li; Yuqiong Li; Jinxiu Lin; Feng Peng; Wenquan Niu
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

7.  Genetic polymorphism of the Nrf2 promoter region is associated with vitiligo risk in Han Chinese populations.

Authors:  Pu Song; Kai Li; Ling Liu; Xiaowen Wang; Zhe Jian; Weigang Zhang; Gang Wang; Chunying Li; Tianwen Gao
Journal:  J Cell Mol Med       Date:  2016-05-25       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.